CoChat

Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review

Itariu, Bianca K., Stulnig, Thomas M. · 2014 · Gerontology

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

Autoimmunity is a well-known pathogenic component in type 1 diabetes (T1DM). The assumption that the pathogenesis of type 2 diabetes (T2DM) also encompasses autoimmune aspects is recognized increasingly, based on the presence of circulating autoantibodies against β cells, self-reactive T cells, but also on the glucose-lowering efficacy of some immunomodulatory therapies in T2DM. The identification of these autoantibodies in elderly patients with slowly progressive manifestation of diabetes led to the introduction of a distinct clinical entity termed latent autoimmune diabetes of the adult (LADA), which combines features of both T1DM and T2DM. The autoantibody cluster differs in patients with LADA from patients with T1DM, but their presence indicates steady progression towards β-cell death and subsequent need for initiation of insulin treatment in a shorter period of time compared to autoantibody-negative T2DM patients. Autoimmune aspects in T2DM are not solely restricted to autoantibodies and thus LADA. They include the self-reactive T cells or defects in regulatory T cells (Tregs), which have been detected in autoantibody-negative T2DM patients as well. One contributor to the autoimmune activation in T2DM seems to be the chronic inflammatory state, characteristic of this disease. Upon inflammation-induced tissue destruction, cryptic ‘self' antigens can trigger an autoimmune response, which in turn accelerates β-cell death. Both innate and adaptive immune system components, specifically macrophages and self-reactive T cells, contribute to an increased secretion of inflammatory cytokines involved in inflammatory and autoimmune processes. However, the extent to which inflammation overlaps with autoimmunity is not known. Our review focuses on autoimmune involvement in T2DM, with an emphasis on LADA and the humoral immune response, on the involvement of chronic inflammation in autoimmunity, and specifically the role of B and T cells as links between inflammatory and autoimmune reactions. We will further stress the consequences of autoimmune activation for T2DM patients and present novel therapeutic approaches for T2DM management that rely on immune modulation.

Overview

Integrity signals

Registry

Crossref · 10.1159/000356747

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. 10.1210/jc.87.3.1184 · doi:10.1210/jc.87.3.1184 · Paper page
  2. 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page

Cited by

See all 107

Metadata

Authors
Itariu, B. K., & Stulnig, T. M.
Affiliations
Medical University of Vienna (AT)
Venue
Gerontology
Publisher
S. Karger AG
Published
2014
Volume
60
Issue
3
Pages
189-196
ISSN
  • 0304-324X (ISSN-L)
  • 1423-0003
OpenAlex
W2043428857
Cited by
107
References
69
Citations by year
2026: 4 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 12 · 2021: 11 · 2020: 9 · 2019: 15 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 5
FWCI
1.46
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gerontology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Research Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
type 2 diabetes, autoimmunity, beta-cell autoantibodies, autoreactive T cells, regulatory T cells, chronic inflammation, beta-cell death, immunomodulatory therapy, B cells, T cells, macrophages, inflammatory cytokines, elderly patients
MeSH terms
Adult, Aged, Animals, Autoimmune Diseases, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glutamate Decarboxylase, Humans, Lymphocytes, Male, Middle Aged, Autoimmunity, Models, Immunological, Insulin-Secreting Cells, Immunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.